Targeted Therapy for Advanced Rare Cancers
PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc
Recruiting
N/A
Interventional Study
Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 30 (estimated)
- Sponsor
- British Columbia Cancer Agency · Other
Who this trial is looking for
This trial is looking for adults with advanced rare cancers who are receiving a specific targeted therapy. Participants will help researchers understand how this treatment affects their quality of life and survival.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 18 years or older.
- I have an incurable cancer with a rare type or molecular change.
- I am currently receiving Health Canada approved targeted therapy.
- I am expected to live at least 12 weeks.
- I have good blood and organ function as assessed by my doctor.
- I have either treated or untreated brain metastases.
- I can give consent for this study.
You may not be able to join if
- I have participated in another clinical trial in the last 14 days.
- I cannot complete quality of life questionnaires.
- My doctor believes I am not fit to participate in this trial.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This pilot clinical trial aims to assess the real world quality of life and survival of patients treated with targeted therapy that has preliminary evidence of efficacy in subjects with advanced rare cancers or cancer harbouring rare molecular aberrations. The treatment has been granted conditional or full approved by Health Canada (HC) as effective and safe. Due to the rarity of the cancer or mol…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Subject age greater than or equal to 18 years at the time of signature of informed consent.
* Subjects with an incurable malignancy who have been identified to have a rare cancer or rare molecular aberration who is currently receiving Health Canada approved targeted therapy th…
Contacts